CVS Health is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the United States in 2026, including a new Roxbury site in the Boston area. The expansion comes as recent headlines have sent mixed signals for investors, with Medicare Advantage star rating setbacks and a legal probe weighing on sentiment, while an extended Cardinal Health distribution deal and a reaffirmed dividend provide a steadier backdrop. Even after a one-day share price decline of 1.87% and a 30-day share price return down 8.98%, the year-to-date share price return of 7.53% and a one-year total shareholder return of 14.11% indicate that longer term holders have still seen gains as shorter term momentum has faded. On the most followed view, CVS Health screens as undervalued, with a fair value of $124 against a last close of $86.16. The company has raised full-year guidance twice through the first half of 2026, Aetna's medical benefit ratio has improved, cash flow is running well ahead of plan, and all three operating segments are growing, though the story could break if Aetna's medical cost trend runs hotter than expected or if pharmacy benefit reforms compress Health Services earnings faster than planned.
CVS Health CorpCVS is opening nearly 20 smaller neighborhood pharmacy locations across the US in 2026, expanding its pharmacy footprint.
Cardinal Health IncCVS extended its Cardinal Health distribution deal, a positive for Cardinal's product supply relationship.
